Publikationen 2019-
2022
- Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immmunogenicity and protective capacity.
Meyer zu Natrup C., Tscherne A., Dahlke C., Ciurkiewicz M., Shin D.-l., Fathi A., Rohde C., Kalodimou G., Halwe S., Limpinsel L., Schwarz J.H., Klug M., Esen M., Schneiderhan-Marra N., Dulovic A., Kupke A., Brosinski K, Clever S, Schünemann L.-M., Beythien G., Armando F., Mayer L., Weskamm L.M., Jany S., Freudenstein A., Tuchel T., Baumgärtner W., Kremsner P., Fendel R., Addo M.M., Becker S., Sutter G., Volz A.
J Clin Invest. 2022 Oct 27; e159895. doi: 10.1172/JCI159895. - Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.
Tscherne A., Mantel E., Boskani T., Budniak S., Elschner M., Fasanella A., Feruglio S.L., Galante D., Giske C.G., Grunow R., Henczko J., Hinz C., Iwaniak W., Jacob D., Kedrak-Jablonska A., Jensen V.K., Johansen T.B., Kahlmeter G., Manzulli V., Matuszek E., Melzer F., Nuncio M.S. Papaparaskevas J., Pelerito A., Solheim M., Thomann S., Tsakris A., Wahab T., Weiner M., Zoeller L., Zange S., EMERGE AST Working Group.
Microorganisms. 2022 Jul 20;10(7):1470. doi: 10.3390/microorganism10071470 - Increased neutralization and IgG epitope identification aftre MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Fathi A., Dahlke C., Krähling V., Kupke A., Okba N.M.A., Raadsen M.P., Heidepriem J., Müller M.A., Paris G., Lassen S., KLüver M., Volz A., Koch T., Ly M.L., Friedrich M., Fux R., Tscherne A., Kalodimou G., Schmiedel S., Corman V.M., Hesterkamp T., Drosten C., Loeffer F.F., Haagmans B.L., Sutter G., Becker S., Addo M.M.
Nature Communications 2022 Jul 19;13(1):4182 https://doi.org/10.1038/s4167-022-31557-0
2021
- Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
Bosnjak B., Odak I., Barros-Martins J., Sandrock I., Hammerschmidt S.I., Permanyer M., Patzer G.E., Greorgiev H., Jauregui R.G., Tscherne A., Schwarz J.H., Kalodimou G., Ssebyatika G., Ciurkiewicz M., Willenzon S., Bubke A., Ristenpart J., Ritter C., Tuchel T., Meyer zu Natrup C., Shin D.-L., Clever S., Limpinsel L., Baumgärtner W., Krey T., Volz A., Sutter G., Förster R.
Frontiers in Immunology 2021 Nov 11, Vol. 12, Article 772240. doi: 10.3389/frmmu.2021.772240e.Collection 2021 - Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. (pdf, 1,36 MB + 1,46 MB)
Tscherne A., Schwarz J.H., Rohde C., Kupke A., Kalodimou G., Limpinsel L., Okba N.M.A., Bosnjak B., Sandrock I., Odak I., Halwe S., Sauerhering L., Brosinski K., Liangliang N., Duell E., Jany S., Freudenstein A., Schmidt J., Werner A., Serra M.G., Klüver M., Guggemos W., Seilmaier M., Wendtner C.-M., Förster R., Haagmans B.L., Becker S., Sutter G., Volz A.
Proc Natl Acad Sci USA 2021 Jul 13;118 e2026207118. doi.org/10.1073/pnas.2026207118
- Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging.
Timofeev O., Koch L., Niederau C., Tscherne A., Schneikert J., Klimovich M., Elmshäuser S., Zeitlinger M., Mernberger M., Nist A., Osterburg C., Dötsch V., German Mouse Clinic Consortium, Hrabe de Angelis M. Stiewe T.
Cancer Res 2020 Dec 1;80(23):5231-5244. doi: 10.1158/0008-5472.CAN-20-2002. Epub 2020 Sep 1. - NOTIFy (non-toxic lyophilized field)-FISH for the identification of biological agents by Fluorescence in situ Hybridization.
Aistleitner K., Sieper T., Stürz I., Jeske R., Tritscheller S., Mantel S., Tscherne A., Zange S., Stoecker K., Wölfel R.
PLoS ONE. 2020 Mar 6;15(3):e0230057. doi: 10.1371/journal.pone.0230057. eCollection 2020.
- Evalution of in vitro antimicrobial susceptibility of Bacillus anthracis strains isolated during anthrax outbreaks in Italy from 1984 to 2017.
Manzulli V., Fasanella A., Parisi A., Serrecchia L., Donatiello A., Rondinone V., Caruso M., Zange S., Tscherne A., Decaro N., Pedarra C., Galante D.
J Vet Sci. 2019 Jan 31;20(1):58-62. doi. 10.4142/jvs.2019.20.1.58